Earnings History Data for Eledon Pharmaceuticals (ELDN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eledon Pharmaceuticals

Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon Pharmaceuticals Inc., formerly known as Novus Therapeutics Inc., is based in IRVINE, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		ELDN	Eledon Pharmaceuticals	192.00	-0.32	-0.30	0.00	Eledon Pharmaceuticals GAAP EPS of -$0.32 misses by $0.02 [11/13/2024 3:54 AM]	4.25	-0.57 (-11.83%)	4.79	-0.03 (-0.62%)	1.11 - 5.54	368,681	800,000	263
Eledon Pharmaceuticals GAAP EPS of -$0.32 misses by $0.02 [11/13/2024 3:54 AM]
19-08-2024	AH		ELDN	Eledon Pharmaceuticals	68.00	-0.32	-0.31	0.00		2.85	0.09 (3.27%)	2.87	0.12 (4.17%)	1.07 - 3.35	60,332	40,000	463

28-03-2024	AH		ELDN	Eledon Pharmaceuticals	51.00	-0.29	-0.38	0.00	Eledon Pharmaceuticals GAAP EPS of -$0.32 beats by $0.07 [3/28/2024 5:09 PM]	2.06	-0.07 (-3.29%)	2.04	-0.02 (-0.97%)	1.07 - 2.95	40,041	160,000	3,904
Eledon Pharmaceuticals GAAP EPS of -$0.32 beats by $0.07 [3/28/2024 5:09 PM]
09-11-2023	AH		ELDN	Eledon Pharmaceuticals	28.00	-0.35	-0.41	0.00	Eledon Pharmaceuticals GAAP EPS of -$0.35 [11/9/2023 5:48 PM]	1.19	0.04 (3.48%)	1.17	0.02 (1.74%)	1.07 - 3.70	30,688	160,000	2,509
Eledon Pharmaceuticals GAAP EPS of -$0.35 [11/9/2023 5:48 PM]
11-05-2023	AH	4:00 PM ET (May 11)	ELDN	Eledon Pharmaceuticals, Inc.	37.89	-0.75	-0.71	-0.69	Eledon Pharmaceuticals GAAP EPS of -$0.75 misses by $0.11 [5/11/2023 4:14 PM]	2.45	-0.32 (-11.55%)	2.80	0.03 (1.08%)	1.68 - 3.95	213,748	690,000	2,028
Eledon Pharmaceuticals GAAP EPS of -$0.75 misses by $0.11 [5/11/2023 4:14 PM]
30-03-2023	AH	4:00 PM ET (Mar 30)	ELDN	Eledon Pharmaceuticals, Inc.	32.33	-0.68	-0.70	-0.59		2.38	-0.13 (-5.18%)	2.71	0.34 (14.52%)	1.90 - 4.14	60,064	30,000	2,300
Eledon tegoprubart shows promise in kidney transplant patients in phase 1b trial [3/31/2023 6:32 AM]
14-11-2022	AH	4:00 PM ET (Nov 14)	ELDN	Eledon Pharmaceuticals, Inc.	33.29	-0.73	-0.68	-0.66	Eledon Pharmaceuticals GAAP EPS of -$0.73 [11/14/2022 4:05 PM]	2.64	-0.10 (-3.65%)	2.80	0.06 (2.19%)	2.27 - 6.04	9,277	10,000	199
Eledon Pharmaceuticals GAAP EPS of -$0.73 [11/14/2022 4:05 PM]
11-08-2022	AH	4:00 PM ET (Aug 11)	ELDN	Eledon Pharmaceuticals, Inc.	37.14	-0.65	-0.72	-0.50	Eledon Pharmaceuticals GAAP EPS of -$0.65 beats by $0.05 [8/11/2022 4:06 PM]	3.44	-0.03 (-0.86%)	3.47	0.0 (0.00%)	2.27 - 8.49	12,355	30,000	100
Eledon Pharmaceuticals GAAP EPS of -$0.65 beats by $0.05 [8/11/2022 4:06 PM] Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results [Aug-11-22 04:01PM]
12-05-2022	AH	4:00 PM ET (May 12)	ELDN	Eledon Pharmaceuticals, Inc.	35.49	-0.69	-0.67	-0.57	Eledon Pharmaceuticals GAAP EPS of -$0.69 [5/12/2022 4:04 PM]	2.64	0.23 (9.51%)	0.0	0.0 (0.00%)	2.27 - 10.20	98,131	10,000	0
Eledon Pharmaceuticals GAAP EPS of -$0.69 [5/12/2022 4:04 PM] Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results [May-12-22 04:01PM]
24-03-2022	AH	4:05 PM ET (Mar 24)	ELDN	Eledon Pharmaceuticals, Inc.	50.35	-0.59	-0.83	0.00	Eledon Pharmaceuticals GAAP EPS of -$2.33 beats by $0.23 [3/24/2022 4:02 PM]	3.91	0.16 (4.27%)	3.70	-0.09 (-2.37%)	2.92 - 11.86	42,169	85,046	2,454
Here's Why We're Watching Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Situation [Mar-24-22 12:58PM] Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results [Mar-24-22 04:01PM]
11-11-2021	AH	4:00 PM ET (Nov 11)	ELDN	Eledon Pharmaceuticals, Inc.	72.11	-0.66	-0.67	-3.91	Eledon Pharmaceuticals EPS misses by $0.03 [11/11/2021 4:07 PM]	5.65	0.70 (14.14%)	5.45	0.50 (10.10%)	4.81 - 26.44	263,370	80,000	18,899
Eledon Pharmaceuticals EPS misses by $0.03 [11/11/2021 4:07 PM] Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results [Nov-11-21 04:05PM]
12-08-2021	AH	4:00 PM ET (Aug 12)	ELDN	Eledon Pharmaceuticals, Inc.	91.42	-0.50	-0.58	-2.70		6.32	0.02 (0.32%)	0.0	0.0 (0.00%)	5.91 - 27.32	455,682	50,000	0
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results [Aug-12-21 04:01PM]
13-05-2021	AH	After the close (May 13)	ELDN	Eledon Pharmaceuticals, Inc.	138.06	-0.57	-0.37	-8.45	Eledon Pharmaceuticals EPS misses by $0.24 [5/13/2021 4:47 PM]	8.86	0.06 (0.68%)	0.0	0.0 (0.00%)	6.16 - 27.32	17,058	20,000	0
Eledon Pharmaceuticals EPS misses by $0.24 [5/13/2021 4:47 PM] Eledon Pharmaceuticals, Inc. to Host Earnings Call [May-13-21 02:30PM] Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results [May-13-21 04:01PM]
30-03-2021	AH	After the close (Mar 30)	ELDN	Eledon Pharmaceuticals, Inc.	150.93	N/A	-0.42	-3.24	Eledon Pharmaceuticals EPS misses by $3.42 [3/30/2021 4:51 PM]	10.64	0.79 (8.02%)	10.55	0.70 (7.11%)	5.40 - 27.32	151,951	100,000	536
Eledon Pharmaceuticals EPS misses by $3.42 [3/30/2021 4:51 PM] What Kind Of Shareholders Own Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)? [Mar-29-21 02:08AM] Eledon Pharmaceuticals, Inc. to Host Earnings Call [Mar-30-21 02:30PM] Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results [Mar-30-21 04:05PM]